<p>CRFK and Jurkat (A), or Hela and Jurkat (B), or PBMCs (C) were infected with VSV G-pseudotyped HIV-1<sub>NL4-3</sub>-GFP, or with isogenic vector bearing the SIV<sub>MAC</sub>239 CA residues 1 to 202. 24 hrs post-infection, DNA was collected from the cells and subjected to qPCR using primers specific for full-length linear viral cDNA, 2-LTR circles, or proviral DNA, as indicated. Shown is the abundance of signal from vector bearing the SIV<sub>MAC</sub>239 CA<sup>1-202</sup>, relative to the amount of signal from HIV-1<sub>NL4-3</sub>-GFP. In each case, infection was performed in the presence of an RT inhibitor to control for background levels of signal.</p
<p>The RT-PCR results from RNA isolated from Jurkat cells infected with HIV-1(MN) and HIV-2 (ROD) to...
<p>BER wild type and deletion cell lines were infected with HIV. DNA was purified at 24 hpi or 72 hp...
<p><b>(A)</b> KG-1 and Jurkat cells were infected with 4070A pseudotyped MLV-EGFP at different MOIs....
<p>(A) Jurkat and HeLa cells stably expressing the ALV-A receptor (TvA) or TagRFP-657, as indicated,...
<p>(A) Transduction efficiency of VSV G-pseudotyped two-part vectors for HIV-1<sub>NL4-3</sub>GFP (w...
<p>(A) Chimeric vectors were generated in which the coding sequence for HIV-1 CA amino acid residues...
(A) Jurkat T cells were transduced and positively selected for indicated CARs and then infected with...
<p>(A) CRFK cells (left panel) and Jurkat T cells (right panel) were transduced with VSV G-pseudotyp...
Jurkat cells were infected as in Fig. 1 with RT- NL4-3virions either with (Vpr) or without (Δ) hVpr ...
<p>TE671 cells (A), Jurkat T cells (B), human PBMC (C), or human CD4<sup>+</sup> T cells (D) were tr...
<p>A) Infectivity in Hela P4 CCR5 over expressing IBD, NOVA 1 PIR and TOX 4 PIR was determined 48 ho...
<p>The relative level of viral replication in TZM-bl cells was measured following incubation with su...
<p><b>A.</b> HIV-1 replication in Jurkat T cells cultured under static or shaking conditions. Jurkat...
(A and B) Jurkat T cells were transduced with the high or low affinity CAR. Cells were stimulated th...
<p>(A) Sorting strategies for MDSCs and CD4<sup>+</sup>T cells from the PBMCs of SIV-infected macaqu...
<p>The RT-PCR results from RNA isolated from Jurkat cells infected with HIV-1(MN) and HIV-2 (ROD) to...
<p>BER wild type and deletion cell lines were infected with HIV. DNA was purified at 24 hpi or 72 hp...
<p><b>(A)</b> KG-1 and Jurkat cells were infected with 4070A pseudotyped MLV-EGFP at different MOIs....
<p>(A) Jurkat and HeLa cells stably expressing the ALV-A receptor (TvA) or TagRFP-657, as indicated,...
<p>(A) Transduction efficiency of VSV G-pseudotyped two-part vectors for HIV-1<sub>NL4-3</sub>GFP (w...
<p>(A) Chimeric vectors were generated in which the coding sequence for HIV-1 CA amino acid residues...
(A) Jurkat T cells were transduced and positively selected for indicated CARs and then infected with...
<p>(A) CRFK cells (left panel) and Jurkat T cells (right panel) were transduced with VSV G-pseudotyp...
Jurkat cells were infected as in Fig. 1 with RT- NL4-3virions either with (Vpr) or without (Δ) hVpr ...
<p>TE671 cells (A), Jurkat T cells (B), human PBMC (C), or human CD4<sup>+</sup> T cells (D) were tr...
<p>A) Infectivity in Hela P4 CCR5 over expressing IBD, NOVA 1 PIR and TOX 4 PIR was determined 48 ho...
<p>The relative level of viral replication in TZM-bl cells was measured following incubation with su...
<p><b>A.</b> HIV-1 replication in Jurkat T cells cultured under static or shaking conditions. Jurkat...
(A and B) Jurkat T cells were transduced with the high or low affinity CAR. Cells were stimulated th...
<p>(A) Sorting strategies for MDSCs and CD4<sup>+</sup>T cells from the PBMCs of SIV-infected macaqu...
<p>The RT-PCR results from RNA isolated from Jurkat cells infected with HIV-1(MN) and HIV-2 (ROD) to...
<p>BER wild type and deletion cell lines were infected with HIV. DNA was purified at 24 hpi or 72 hp...
<p><b>(A)</b> KG-1 and Jurkat cells were infected with 4070A pseudotyped MLV-EGFP at different MOIs....